Iridian Asset Management LLC Nuvectis Pharma, Inc. Call Options Transaction History
Iridian Asset Management LLC
- $304 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVCT
# of Institutions
34Shares Held
2.23MCall Options Held
0Put Options Held
0-
Ronit Capital LLP563KShares$5.81 Million5.37% of portfolio
-
Baldwin Brothers LLC358KShares$3.7 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$3.36 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0125KShares$1.29 Million0.0% of portfolio
-
Black Rock Inc. New York, NY83.4KShares$861,6450.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $151M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...